Your browser doesn't support javascript.
loading
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.
Shabason, Jacob E; Chen, Jerry; Apisarnthanarax, Smith; Damjanov, Nevena; Giantonio, Bruce; Loaiza-Bonilla, Arturo; O'Dwyer, Peter J; O'Hara, Mark; Reiss, Kim A; Teitelbaum, Ursina; Wissel, Paul; Drebin, Jeffrey A; Vollmer, Charles; Kochman, Michael; Mick, Rosemarie; Vergara, Norge; Jhala, Nirag; Doucette, Abigail; Lukens, John N; Plastaras, John P; Metz, James M; Ben-Josef, Edgar.
Afiliación
  • Shabason JE; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA. jacob.shabason@uphs.upenn.edu.
  • Chen J; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.
  • Apisarnthanarax S; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
  • Damjanov N; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Giantonio B; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Loaiza-Bonilla A; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • O'Dwyer PJ; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • O'Hara M; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Reiss KA; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Teitelbaum U; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Wissel P; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Drebin JA; Department of Surgery, Memorial Sloane Kettering Cancer Center, New York, NY, USA.
  • Vollmer C; Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Kochman M; Gastroenterology Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Mick R; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Vergara N; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Jhala N; Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, PA, USA.
  • Doucette A; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.
  • Lukens JN; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.
  • Plastaras JP; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.
  • Metz JM; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.
  • Ben-Josef E; Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, PCAM-2 West, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.
Cancer Chemother Pharmacol ; 81(3): 609-614, 2018 03.
Article en En | MEDLINE | ID: mdl-29362902
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos